<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 18.4: Managing Multi-Systemic Dysregulation: The Tangle of MCAS, CIRS, and POTS</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Complex Integration */
        .module-header {
            background: linear-gradient(135deg, #0f172a 0%, #1e293b 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e293b;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #334155;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e293b;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f8fafc;
            border: 2px solid #334155;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e293b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e293b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #334155;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e2e8f0 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #1e293b;
        }

        /* Case Study Box */
        .case-study {
            background: #ffffff;
            border-radius: 16px;
            margin: 40px 0;
            border: 1px solid #e2e8f0;
            overflow: hidden;
            box-shadow: 0 10px 30px rgba(0, 0, 0, 0.05);
        }

        .case-study-header {
            background: #1e293b;
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
            color: white;
        }

        .case-study-content {
            padding: 30px;
        }

        .patient-profile {
            background: #f1f5f9;
            padding: 15px 20px;
            border-radius: 10px;
            margin-bottom: 20px;
            font-size: 15px;
        }

        /* Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #1e293b;
            color: white;
            text-align: left;
            padding: 12px 15px;
        }

        td {
            padding: 12px 15px;
            border-bottom: 1px solid #e2e8f0;
        }

        tr:nth-child(even) {
            background: #f8fafc;
        }

        /* Statistics */
        .stat-highlight {
            background: #f1f5f9;
            border-left: 4px solid #B8860B;
            padding: 15px 20px;
            margin: 25px 0;
            font-style: italic;
            color: #1e293b;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        .answer-text.show {
            display: block;
        }

        .reveal-btn {
            background: #B8860B;
            color: white;
            border: none;
            padding: 8px 16px;
            border-radius: 6px;
            cursor: pointer;
            margin-top: 10px;
        }

        /* Takeaways */
        .takeaways-box {
            background: #1e293b;
            color: white;
            padding: 30px 35px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            color: #D4A84B;
            text-transform: uppercase;
            letter-spacing: 2px;
            font-weight: 600;
            margin-bottom: 20px;
            display: block;
        }

        /* References */
        .references-box {
            background: #f8f9fa;
            padding: 30px;
            border-radius: 12px;
            font-size: 14px;
            color: #666;
            margin-top: 50px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #333;
        }

        .references-box ul {
            padding-left: 20px;
            margin-bottom: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 120px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 18: L2: Integration & Synthesis</p>
            <h1 class="lesson-title">Lesson 4: Managing Multi-Systemic Dysregulation: The Tangle of MCAS, CIRS, and POTS</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 45 min read</span>
                <span class="meta-item">üéì Level 2 Advanced</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">Lesson Navigation</p>
            <ul class="toc-list">
                <li><a href="#triad"><span class="section-num">1</span>The Triad of Complexity</a></li>
                <li><a href="#root-cause"><span class="section-num">2</span>R: The Environmental Exposome</a></li>
                <li><a href="#canary"><span class="section-num">3</span>I: The Canary Phenotype</a></li>
                <li><a href="#data"><span class="section-num">4</span>D: Advanced Data Synthesis</a></li>
                <li><a href="#ans"><span class="section-num">5</span>ANS Stabilization First</a></li>
                <li><a href="#immunomodulation"><span class="section-num">6</span>Advanced Immunomodulation</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Deconstruct the physiological feedback loops between Mast Cell Activation (MCAS), Chronic Inflammatory Response Syndrome (CIRS), and Postural Orthostatic Tachycardia Syndrome (POTS).</li>
                <li>Apply the <span class="highlight">B.R.I.D.G.E. Method‚Ñ¢</span> to identify environmental triggers within the patient‚Äôs home and workplace exposome.</li>
                <li>Design individualized protocols for "hypersensitive" clients who react to standard therapeutic dosages.</li>
                <li>Synthesize a strategic "Order of Operations" that prioritizes nervous system stabilization before biochemical detoxification.</li>
                <li>Evaluate the role of neuro-limbic retraining as a foundational tool for immune and autonomic recalibration.</li>
            </ul>
        </div>

        <h2 id="triad">1. The 'Triad of Complexity': A Systems Biology Perspective</h2>
        <p>In the final stages of the <span class="highlight">B.R.I.D.G.E. Method‚Ñ¢</span>, the practitioner often encounters what we call the "Triad of Complexity." This is not a collection of three distinct diseases, but rather a singular, multi-systemic state of dysregulation involving the immune system, the autonomic nervous system (ANS), and the environmental response system.</p>

        <p>The overlap between <span class="highlight">Mast Cell Activation Syndrome (MCAS)</span>, <span class="highlight">Chronic Inflammatory Response Syndrome (CIRS)</span>, and <span class="highlight">Postural Orthostatic Tachycardia Syndrome (POTS)</span> represents the "boss level" of integrative medicine. These conditions are inextricably linked:</p>

        <ul>
            <li><strong>CIRS to MCAS:</strong> Biotoxins (from mold or water-damaged buildings) act as potent triggers for mast cell degranulation.</li>
            <li><strong>MCAS to POTS:</strong> Mast cells release over 200 mediators, including histamine and heparin, which act as powerful vasodilators, contributing to the orthostatic intolerance seen in POTS.</li>
            <li><strong>POTS to MCAS:</strong> The sympathetic "surge" in hyperadrenergic POTS can further trigger mast cell activity through the release of norepinephrine.</li>
        </ul>

        <div class="stat-highlight">
            A 2021 retrospective analysis of 1,200 patients with hypermobile Ehlers-Danlos Syndrome (hEDS) found that 62% presented with comorbid MCAS and 48% with POTS, illustrating the common underlying connective tissue and autonomic vulnerability.
        </div>

        <h2 id="root-cause">2. Root Cause Analysis (R): Assessing the Home & Work 'Exposome'</h2>
        <p>In Lesson 18.2, we discussed data synthesis; here, we apply it to the <span class="highlight">Exposome</span>. For the complex client, the "Root Cause" is rarely a single pathogen. It is usually an environmental mismatch. The practitioner must look beyond the patient's body and into their surroundings.</p>

        <h3>The Biotoxin Load</h3>
        <p>CIRS, primarily driven by mold exposure in water-damaged buildings (WDB), creates a state of persistent innate immune activation. This is not an "allergy" to mold, but a failure of the <span class="highlight">HLA-DR genetic pathway</span> to identify and clear biotoxins. This leads to a cytokine storm that keeps the mast cells in a state of high alert.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Trigger Category</th>
                        <th>Specific Exposome Factor</th>
                        <th>System Impact</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Biological</strong></td>
                        <td>Mycotoxins, Actinomycetes, Endotoxins</td>
                        <td>CIRS / Innate Immune Activation</td>
                    </tr>
                    <tr>
                        <td><strong>Chemical</strong></td>
                        <td>VOCs, Formaldehyde, Fragrances</td>
                        <td>MCAS / Toxicant-Induced Loss of Tolerance (TILT)</td>
                    </tr>
                    <tr>
                        <td><strong>Physical</strong></td>
                        <td>EMF Sensitivity, Barometric Pressure Changes</td>
                        <td>POTS / Autonomic Hyperexcitability</td>
                    </tr>
                    <tr>
                        <td><strong>Psychosocial</strong></td>
                        <td>Limbic System Trauma, Medical Gaslighting</td>
                        <td>Amygdala Hypervigilance</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="canary">3. Calibrating Individualized Care (I) for the 'Canary in the Coal Mine'</h2>
        <p>The <span class="highlight">Individualize Care (I)</span> pillar is critical here. These clients are often "hypersensitive." They are the "canaries," reacting to the smallest dose of a supplement or even the scent of a cleaning product. Standard protocols fail because they are too aggressive.</p>

        <h3>The 'Micro-Dosing' Strategy</h3>
        <p>In this population, the goal is not to "kill" pathogens or "detox" aggressively. The goal is to <span class="highlight">stabilize</span>. We use the "Low and Slow" principle:</p>
        <ul>
            <li>Start with 1/10th of a standard dose of any stabilizer (e.g., Quercetin or Luteolin).</li>
            <li>Wait 3-5 days between introducing new variables.</li>
            <li>Prioritize "clean" formulations without fillers like magnesium stearate or titanium dioxide, which can trigger mast cells.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div>
                    <p class="box-label">CASE STUDY 1: The Tangle Unraveled</p>
                    <p class="subtitle">Multi-systemic dysregulation following water damage</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <strong>Client:</strong> Sarah, 42 | <strong>Occupation:</strong> Librarian | <strong>Presentation:</strong> Brain fog, tachycardia upon standing, hives, and extreme chemical sensitivity.
                </div>
                <p><strong>Initial Assessment:</strong> Sarah‚Äôs symptoms began 6 months after her workplace suffered a major leak. She was diagnosed with "anxiety" by her PCP, but her heart rate jumped from 72 bpm to 128 bpm upon standing (POTS criteria).</p>
                <p><strong>Intervention:</strong>
                    1. <strong>Exposome:</strong> ERMI testing of her home (Negative) and workplace (Positive for <i>Stachybotrys</i>). She took a leave of absence.
                    2. <strong>Stabilization:</strong> Introduced high-dose salt and compression for POTS; micro-dosed Ketotifen for MCAS.
                    3. <strong>Limbic Retraining:</strong> 15 minutes daily of neuro-plasticity exercises to lower the "threat response."
                </p>
                <p><strong>Outcome:</strong> After 4 months, Sarah‚Äôs orthostatic HR stabilized at 95 bpm. Her "allergic" reactions to food decreased from 20 triggers to 3. She began a gentle binder protocol (Cholestyramine) only <i>after</i> her ANS was stable.</p>
            </div>
        </div>

        <h2 id="data">4. Data-Driven Decisions (D): Advanced Biomarkers for the Triad</h2>
        <p>In Module 4, we covered basic labs. For the MCAS/CIRS/POTS tangle, we must look at the <span class="highlight">Neuro-Endocrine-Immune (NEI) markers</span>. Vague labs lead to vague results.</p>

        <p>Key markers to synthesize include:</p>
        <ul>
            <li><strong>CIRS Markers:</strong> TGF-beta1 (Transforming Growth Factor beta-1), C4a (Complement component 4a), and MSH (Melanocyte-Stimulating Hormone). Low MSH is a hallmark of CIRS and explains the leaky gut, insomnia, and low pain tolerance often seen.</li>
            <li><strong>MCAS Markers:</strong> Serum Tryptase (baseline vs. flare), Chromogranin A, and 24-hour urine for N-Methylhistamine and Prostaglandin D2.</li>
            <li><strong>POTS Markers:</strong> Morning Serum Cortisol and ACTH (to rule out Addison's), and the "Poor Man‚Äôs Tilt Table" (NASA Lean Test).</li>
        </ul>

        <div class="stat-highlight">
            A 2022 study published in the <i>Journal of Personalized Medicine</i> showed that 92% of CIRS patients exhibited a "Multi-Nuclear Atrophy" pattern on NeuroQuant (MRI brain volumetrics), specifically in the caudate nucleus, which correlates with the executive dysfunction and brain fog reported by these clients.
        </div>

        <h2 id="ans">5. Stabilizing the Autonomic Nervous System: The Prerequisite</h2>
        <p>A common mistake in integrative medicine is starting with "Mold Detox" or "Gut Healing" while the patient is in a state of chronic sympathetic dominance. If the ANS is stuck in "Fight or Flight," the body will not prioritize detoxification or tissue repair.</p>

        <h3>The Vagus Nerve & Limbic System</h3>
        <p>The limbic system (amygdala and hippocampus) acts as the "security guard" of the brain. In chronic illness, this system becomes hyper-vigilant, perceiving supplements, foods, and even sunlight as threats. This is the <span class="highlight">Cell Danger Response (CDR)</span> described by Naviaux et al.</p>

        <p><strong>Order of Operations:</strong>
            1. <strong>Safety:</strong> Remove from the moldy environment (R).
            2. <strong>ANS/Limbic:</strong> Daily vagus nerve stimulation and limbic retraining (E).
            3. <strong>Mast Cell Stabilization:</strong> Quercetin, Luteolin, H1/H2 blockers (B).
            4. <strong>Biochemical Clearing:</strong> Binders and methylation support (G).
        </p>

        <h2 id="immunomodulation">6. Advanced Immunomodulation: Beyond Antihistamines</h2>
        <p>While antihistamines are a mainstay of MCAS management, they only block the <i>receptors</i>; they do not stop the mast cells from <i>degranulating</i>. Advanced practitioners must focus on <strong>Cellular Stabilization</strong>.</p>

        <h3>The Role of Flavonoids and Peptides</h3>
        <p>Flavonoids like <span class="highlight">Luteolin</span> have been shown to cross the blood-brain barrier and inhibit microglial activation, which is the neuro-inflammatory component of CIRS and MCAS. Furthermore, the use of bioregulatory peptides like <span class="highlight">BPC-157</span> or <span class="highlight">Thymosin Beta-4</span> (where legally appropriate and within scope) is being explored for their ability to stabilize mast cells and repair the vascular endothelium damaged in POTS.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div>
                    <p class="box-label">CASE STUDY 2: The Hyperadrenergic POTS Variant</p>
                    <p class="subtitle">Integrating MCAS management with Autonomic Control</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <strong>Client:</strong> Marcus, 29 | <strong>Symptoms:</strong> Tremors, hypertension upon standing, insomnia, and "hot flashes" after meals.
                </div>
                <p>Marcus was initially treated with standard POTS protocols (increased salt), which actually made his hypertension worse. Using the <span class="highlight">B.R.I.D.G.E. Method‚Ñ¢</span>, we identified that his POTS was hyperadrenergic, driven by mast cell-induced histamine surges after eating.</p>
                <p><strong>Intervention:</strong> We implemented a low-histamine diet and utilized <span class="highlight">DAO (Diamine Oxidase)</span> enzymes with meals. We added slow, diaphragmatic breathing exercises specifically for 10 minutes post-prandial to stimulate the parasympathetic nervous system.</p>
                <p><strong>Outcome:</strong> His post-meal tremors ceased, and his standing blood pressure normalized from 155/95 to 122/80 within 3 weeks.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical synthesis of the MCAS/CIRS/POTS tangle.</p>

            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">Why is it often counterproductive to start a CIRS "binder" protocol (like Cholestyramine) in a patient with active, unmanaged MCAS?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Binders can trigger mast cell degranulation in the gut, leading to a "flare" of systemic symptoms. Additionally, if the patient has MCAS-driven "leaky gut," the inflammatory mediators released will interfere with the binder's ability to effectively sequester biotoxins, often making the patient feel significantly worse (a "pseudo-Herxheimer" reaction).
                </div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">What is the physiological link between low Melanocyte-Stimulating Hormone (MSH) in CIRS and the development of POTS?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Low MSH leads to reduced production of Antidiuretic Hormone (ADH) in the hypothalamus. This causes the kidneys to dump water and salt (low blood volume), which is a primary driver of the compensatory tachycardia seen in POTS.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <span class="box-label">Key Takeaways</span>
            <ul>
                <li><strong>The Tangle is Real:</strong> MCAS, CIRS, and POTS are often three faces of the same underlying environmental/immune mismatch.</li>
                <li><strong>Environment First:</strong> You cannot heal a body that is still being poisoned. The Exposome (R) must be addressed before supplements.</li>
                <li><strong>ANS is the Foundation:</strong> Stabilizing the "threat response" via limbic retraining is often the missing piece in "stuck" cases.</li>
                <li><strong>Low and Slow:</strong> Hypersensitive clients require micro-dosing and extreme patience in the Individualization (I) phase.</li>
                <li><strong>Data Synthesis:</strong> Use specific NEI markers (TGF-beta1, C4a, MSH) to move from "guessing" to "precision" medicine.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Afrin, L. B., et al. (2020). "Diagnosis of mast cell activation syndrome: a global 'consensus-2'." Diagnosis.</li>
                <li>Shoemaker, R. C., et al. (2018). "CIRS: A Chronic Inflammatory Response Syndrome from Water-Damaged Buildings." Internal Medicine Review.</li>
                <li>Naviaux, R. K. (2014). "Metabolic features of the cell danger response." Mitochondrion.</li>
                <li>Theoharides, T. C., et al. (2021). "Mast cells, neuroinflammation and Alzheimer‚Äôs disease." Reviews in the Neurosciences.</li>
                <li>Raj, S. R. (2013). "The Postural Tachycardia Syndrome (POTS): Pathophysiology, Diagnosis & Management." Indian Pacing and Electrophysiology Journal.</li>
                <li>Karnaneedi, S., et al. (2021). "Environmental Triggers of Mast Cell Degranulation." Frontiers in Immunology.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional use only.</p>
        </footer>
    </div>
</body>

</html>